NCT00003092 arm group 9fab0945b0ae4f7c78a778811b9935ca [clinicaltrials_resource:NCT00003092/arm-group/9fab0945b0ae4f7c78a778811b9935ca]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003092 arm group 9fab0945b0ae4f7c78a778811b9935ca [clinicaltrials_resource:NCT00003092/arm-group/9fab0945b0ae4f7c78a778811b9935ca]
Bio2RDF identifier
NCT00003092/arm-group/9fab0945b0ae4f7c78a778811b9935ca
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ab0945b0ae4f7c78a778811b9935ca
description [clinicaltrials_vocabulary:description]
Patients receive a single dose ...... ase progression, and survival.
identifier
clinicaltrials_resource:NCT00003092/arm-group/9fab0945b0ae4f7c78a778811b9935ca
title
NCT00003092 arm group 9fab0945b0ae4f7c78a778811b9935ca
@en
type
label
NCT00003092 arm group 9fab0945 ...... b0945b0ae4f7c78a778811b9935ca]
@en